Literature DB >> 14209763

THROMBOLYTIC THERAPY.

A S DOUGLAS, G P MCNICOL.   

Abstract

Keywords:  AMINOCAPROIC ACID; ANTICOAGULANTS; CLINICAL RESEARCH; DRUG THERAPY; FIBRINOGEN; FIBRINOLYSIN; HEMORRHAGE; PLASMINOGEN; PULMONARY EMBOLISM; REVIEW; STREPTODORNASE AND STREPTOKINASE; THROMBOPHLEBITIS; THROMBOSIS; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14209763     DOI： 10.1093/oxfordjournals.bmb.a070337

Source DB:  PubMed          Journal:  Br Med Bull        ISSN： 0007-1420            Impact factor:   4.291


× No keyword cloud information.
  5 in total

1.  STUDIES WITH COMPLAMIN, A NICOTINIC-ACID-THEOPHYLLINE ESTER, AS A FIBRINOLYTIC AGENT.

Authors:  G P MCNICOL; A S DOUGLAS
Journal:  Br Med J       Date:  1965-05-01

2.  Automatic determination of euglobulin lysis time.

Authors:  J D Cash; E Leask
Journal:  J Clin Pathol       Date:  1965-11       Impact factor: 3.411

Review 3.  Streptokinase: a review of its clinical pharmacology, mechanism of action and therapeutic uses.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1973       Impact factor: 9.546

4.  A first-in-human phase I trial of locally delivered human plasmin for hemodialysis graft occlusion.

Authors:  R D Shlansky-Goldberg; A H Matsumoto; G A Baumbach; J B Siegel; R D Raabe; T P Murphy; C Deng; J Ray Dawkins; V J Marder
Journal:  J Thromb Haemost       Date:  2008-04-02       Impact factor: 5.824

Review 5.  Pre-clinical studies of plasmin: superior benefit-to-risk ratio of plasmin compared to tissue plasminogen activator.

Authors:  Victor J Marder
Journal:  Thromb Res       Date:  2008-08-22       Impact factor: 3.944
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.